About Christopher Angermayer
Form D filings for SeqOnce BioSciences from 2018 to 2024 list Christopher Angermayer as chief executive officer and director.
Christopher Angermayer first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Angermayer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Angermayer works with at each company, as listed on that company's latest Form D.
SeqOnce BioSciences, Inc. · Form D, Nov 5, 2024
JD
Joseph Dunham
Director